Even though gpNMB is considered to be a potent angiogenic factor in gammopathies and multiple myeloma, the extent to which if any, it contributes to the pathogenesis of the cancer and its progression is unknown. The gene discussed is GPNMB; the disease is plasma cell myeloma.